Global Antisense and RNAi Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Antisense and RNAi Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 RNA Interference
  • 1.4.3 Antisense RNA
• 1.5 Market by Application
  • 1.5.1 Global Antisense and RNAi Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Antisense and RNAi Therapeutics Market Perspective (2015-2026)
• 2.2 Global Antisense and RNAi Therapeutics Growth Trends by Regions
  • 2.2.1 Antisense and RNAi Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Antisense and RNAi Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Antisense and RNAi Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Antisense and RNAi Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Antisense and RNAi Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Antisense and RNAi Therapeutics Players by Market Size
  • 3.1.1 Global Top Antisense and RNAi Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Antisense and RNAi Therapeutics Market Concentration Ratio
  • 3.2.1 Global Antisense and RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Revenue in 2019
• 3.3 Antisense and RNAi Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Antisense and RNAi Therapeutics Product Solution and Service
• 3.5 Date of Enter into Antisense and RNAi Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Antisense and RNAi Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Antisense and RNAi Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Antisense and RNAi Therapeutics Market Size (2015-2020)
• 6.2 Antisense and RNAi Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Antisense and RNAi Therapeutics Market Size (2015-2020)
• 7.2 Antisense and RNAi Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Antisense and RNAi Therapeutics Market Size (2015-2020)
• 8.2 Antisense and RNAi Therapeutics Key Players in China (2019-2020)
• 8.3 China Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 8.4 China Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Antisense and RNAi Therapeutics Market Size (2015-2020)
• 9.2 Antisense and RNAi Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Antisense and RNAi Therapeutics Market Size (2015-2020)
• 10.2 Antisense and RNAi Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Antisense and RNAi Therapeutics Market Size (2015-2020)
• 11.2 Antisense and RNAi Therapeutics Key Players in India (2019-2020)
• 11.3 India Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 11.4 India Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Antisense and RNAi Therapeutics Market Size (2015-2020)
• 12.2 Antisense and RNAi Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Antisense and RNAi Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Antisense and RNAi Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Tekmira Pharmaceuticals
  • 13.1.1 Tekmira Pharmaceuticals Company Details
  • 13.1.2 Tekmira Pharmaceuticals Business Overview
  • 13.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
  • 13.1.4 Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020))
  • 13.1.5 Tekmira Pharmaceuticals Recent Development
• 13.2 Arbutus Biopharma
  • 13.2.1 Arbutus Biopharma Company Details
  • 13.2.2 Arbutus Biopharma Business Overview
  • 13.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
  • 13.2.4 Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.2.5 Arbutus Biopharma Recent Development
• 13.3 Alnylam Pharmaceuticals
  • 13.3.1 Alnylam Pharmaceuticals Company Details
  • 13.3.2 Alnylam Pharmaceuticals Business Overview
  • 13.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
  • 13.3.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.3.5 Alnylam Pharmaceuticals Recent Development
• 13.4 Antisense Therapeutics
  • 13.4.1 Antisense Therapeutics Company Details
  • 13.4.2 Antisense Therapeutics Business Overview
  • 13.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
  • 13.4.4 Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.4.5 Antisense Therapeutics Recent Development
• 13.5 Silence Therapeutics
  • 13.5.1 Silence Therapeutics Company Details
  • 13.5.2 Silence Therapeutics Business Overview
  • 13.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
  • 13.5.4 Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.5.5 Silence Therapeutics Recent Development
• 13.6 Isis Pharmaceuticals
  • 13.6.1 Isis Pharmaceuticals Company Details
  • 13.6.2 Isis Pharmaceuticals Business Overview
  • 13.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
  • 13.6.4 Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.6.5 Isis Pharmaceuticals Recent Development
• 13.7 Sirnaomics
  • 13.7.1 Sirnaomics Company Details
  • 13.7.2 Sirnaomics Business Overview
  • 13.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
  • 13.7.4 Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.7.5 Sirnaomics Recent Development
• 13.8 Santaris
  • 13.8.1 Santaris Company Details
  • 13.8.2 Santaris Business Overview
  • 13.8.3 Santaris Antisense and RNAi Therapeutics Introduction
  • 13.8.4 Santaris Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.8.5 Santaris Recent Development
• 13.9 Roche
  • 13.9.1 Roche Company Details
  • 13.9.2 Roche Business Overview
  • 13.9.3 Roche Antisense and RNAi Therapeutics Introduction
  • 13.9.4 Roche Revenue in Antisense and RNAi Therapeutics Business (2015-2020)
  • 13.9.5 Roche Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer